MICAL2 and glioblastoma: Specifically, through immunohistochemistry, the expression of the MICAL2 protein was highlighted in ECs of neo-angiogenic capillaries branching off within the tumor mass of gastric, kidney, and breast carcinoma, glioblastoma, and cardiac myxoma [13].